Irritation and Sensitization Study of HP-5000 Topical System

Completed · Phase 1 · Has a placebo group

Conditions studied: Osteoarthritis of the Knee

In brief

This study will assess skin irritation and sensitization for HP-5000 patch in healthy subjects.

Key facts

Study ID

NCT04882319

Run by

Noven Pharmaceuticals, Inc.

People needed

200

Starts

2021-06-03

Expected to finish

2022-03-11

Last updated by the study team

2022-08-23

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subject provides written informed consent prior to entering the study or undergoing any study procedures;
• Subject is a generally healthy male or female 18 to 65 years of age;
• Subject is considered to be healthy on the basis of medical history, physical examination, vital signs, normal electrocardiogram (ECG) and clinical laboratory test results.

You may not qualify if…

• Subject is pregnant or lactating, or females planning a pregnancy during the course of the trial;
• Subject has severe cardiac, renal or hepatic impairment;
• Subject has used any topical drugs at the patch application site within 72 hours prior to dosing.

Where it is running

• TKL Research — Fair Lawn, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.